Login

Shu Wang

ORCID: 0000-0002-2558-1492
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5000157700
Research Areas
  • Extracellular vesicles in disease
  • Nanoplatforms for cancer theranostics
  • Nanoparticle-Based Drug Delivery
  • MicroRNA in disease regulation
  • RNA Interference and Gene Delivery
  • Phagocytosis and Immune Regulation

Shenyang Pharmaceutical University
 2022-2025

 M1 Macrophage Membrane-coated Nickel-arsenic Nanocomplex Promoting Synergistic Treatment of Hepatocellular Carcinoma
OPENALEX - Publications 
Shu Wang Ye Gong Yang Ji Dandan Liu Hao Pan and 1 more Weisan Pan

10.1016/j.xphs.2025.01.010 article EN Journal of Pharmaceutical Sciences 2025-01-01
 Microvesicles as drug delivery systems: A new frontier for bionic therapeutics in cancer
OPENALEX - Publications 
Shu Wang Ce Li Yichao Yuan Youxiang Xiong Hangjun Xu and 3 more Weisan Pan Hao Pan Zhihong Zhu

10.1016/j.jddst.2022.104088 article EN Journal of Drug Delivery Science and Technology 2022-12-17
 Membrane-camouflaged biomimetic nanoplatform with arsenic complex for synergistic reinforcement of liver cancer therapy
OPENALEX - Publications 
Shu Wang Yupei Su Jiayang Li Tianyi Wang Hao Pan and 1 more Weisan Pan

Arsenic has excellent anti-advanced liver cancer effects through a variety of pathways, but its severe systemic toxicity forces the need for safe and effective delivery strategy.

10.1080/17435889.2024.2393076 article EN Nanomedicine 2024-09-04
Coming Soon ...